Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
American Journal of Ophthalmology
|
December 28, 1999
Irreversible corneal decompensation in patients treated with topical dorzolamide
I Adamsons
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
August 1, 1992
Visual function after photorefractive keratectomy
I Adamsons
Journal of the American Optometric Association
|
August 11, 1998
A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life
K Strohmaier, E Snyder, I Adamsons
Ophthalmology
|
December 22, 1999
The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components
K Strohmaier, E Snyder, H DuBiner, et al.
Ophthalmology
|
October 27, 1998
The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group
K Strohmaier, E Snyder, H DuBiner, et al.
Puerto Rico Health Sciences Journal
|
June 1, 1993
Visual function after surgery for early cataract
I Adamsons, G S Rubin, W J Stark
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
July 1, 1991
Prevalence of lens opacities in surgical and general populations
I Adamsons, B Muñoz, C Enger, et al.
Clinical Therapeutics
|
September 1, 1996
Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life
R Laibovitz, J Boyle, E Snyder, et al.
The British Journal of Ophthalmology
|
January 30, 1999
Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group
J Hutzelmann, S Owens, A Shedden, et al.
Clinical Therapeutics
|
July 15, 1998
Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group
C Rusk, E Sharpe, J Laurence, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
American Journal of Ophthalmology
|
December 28, 1999
Irreversible corneal decompensation in patients treated with topical dorzolamide
I Adamsons
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
August 1, 1992
Visual function after photorefractive keratectomy
I Adamsons
Journal of the American Optometric Association
|
August 11, 1998
A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life
K Strohmaier, E Snyder, I Adamsons
Ophthalmology
|
December 22, 1999
The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components
K Strohmaier, E Snyder, H DuBiner, et al.
Ophthalmology
|
October 27, 1998
The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group
K Strohmaier, E Snyder, H DuBiner, et al.
Puerto Rico Health Sciences Journal
|
June 1, 1993
Visual function after surgery for early cataract
I Adamsons, G S Rubin, W J Stark
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
July 1, 1991
Prevalence of lens opacities in surgical and general populations
I Adamsons, B Muñoz, C Enger, et al.
Clinical Therapeutics
|
September 1, 1996
Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life
R Laibovitz, J Boyle, E Snyder, et al.
The British Journal of Ophthalmology
|
January 30, 1999
Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group
J Hutzelmann, S Owens, A Shedden, et al.
Clinical Therapeutics
|
July 15, 1998
Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group
C Rusk, E Sharpe, J Laurence, et al.
Page
of 2